post-thrombotic syndrome
Conditions
Interventions
test group:Buyang Huanwu Decoction
test group:Oral Rivaroxaban Tablets
Sponsors
Wangjing Hospital of CACMS
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Conform to the above-mentioned diagnosis of deep vein thrombosis of lower extremities (medical history + ultrasound + laboratory examination); (2) aged between 30 and 75 years old; (3) not receiving systemic anticoagulation; (4) no serious cardiac, Patients with primary diseases or mental diseases such as brain, liver, kidney, malignant tumor and hematopoietic system; (5) Patients are suitable and willing to accept clinical trials and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Under 30 years old or older than 75 years old; (2) Those with recurrent DVT, or a definite diagnosis of PTS; (3) Those who have received or plan to receive systemic intravenous thrombolysis, catheter-based thrombolysis or incision for thrombectomy, (4) Patients with absolute contraindications to anticoagulation (subarachnoid and intracerebral hemorrhage, severe active hemorrhage, malignant hypertension, recent brain, eye, and spine surgery) or relative contraindications (active gastrointestinal bleeding, hemorrhagic constitution, recent stroke, recent major surgery); (5) pregnant and lactating women; (6) complicated with severe cardiovascular, renal, hepatic, peptic ulcer, hematopoietic system (7) Those who suffer from mental illness or other reasons for not cooperating; (8) Those who are allergic or known to be allergic to the drugs and their components used in this test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Villalta score;Lower extremity circumference difference measurement;Color Doppler examination of lower extremity veins; | — |
Countries
China
Contacts
Public ContactWU XIN
Wangjing Hospital of CACMS
Outcome results
None listed